Piramal settles desflurane litigation with Baxter, set to begin US manufacture in 2012

Piramal Critical Care, part of India's Piramal group, can manufacture desflurane, a generic version of Baxter's Suprane inhaled anaesthetic agent, in the US next year as part of a patent litigation settlement for the product.

More from India

More from Focus On Asia